Pakistan Medicines & Pharma IntelligenceMedicine data  •  Company portfolios  •  Price records
MedInfoBaseMedicines · Evidence · Intelligence
Home / Generic medicine
Generic medicine

Clozapine

Clozapine

Data statusRegistration & price fields require source verification.
38brands/products
19companies
38with current prices
Advertisement · clearly labelled sponsored placement
Pakistan brand index

Available brands

38 results
Reset
BrandManufacturerStrengthFormPackReg. no.Official price
AmlepoAmarant Pharmaceuticals Private Limited25 mgTablet5 x10 's075889PKR 1,652.252026-07-23
AmlepoAmarant Pharmaceuticals Private Limited100 mgTablet5 x10 's070497PKR 3,614.282026-07-23
Bio-zapineBio-Labs(Pvt) Ltd100 mgTablet5x10's089534PKR 3,537.102026-07-27
Bio-zapineBio-Labs(Pvt) Ltd25 mgTablet5x10's089535PKR 1,616.232026-07-27
BiopineBiogen Pharma25 mgTablet50’s073148PKR 1,520.692025-09-04
BiopineBiogen Pharma100 mgTablet50’s073149PKR 3,326.522025-09-04
CalianaMartin Dow Limited100 mgTablet5x10's085689PKR 3,490.792026-07-22
CalianaMartin Dow Limited25 mgTablet5x10's085688PKR 1,595.792026-07-22
CLOZARILAGP Limited100 MGTablet50's097362PKR 7,345.772026-07-27
CLOZARILAGP Limited25 mgTablet50's097361PKR 2,322.572026-07-27
ClozegalNAVEGAL LABORATORIES25 mgTablet5x10's110405PKR 1,477.272026-07-30
ClozegalNAVEGAL LABORATORIES100 mgTablet5x10's110404PKR 3,231.522026-07-30
ClozinNovaMed Pharmaceuticals(Pvt.)Ltd100 mgTablet5x10's054151PKR 3,613.572026-07-23
ClozinNovaMed Pharmaceuticals(Pvt.)Ltd25 mgTablet5x10's054150PKR 1,651.922026-07-23
CLOZTECPanacea Pharmaceuticals25 mgTablet50054956PKR 1,574.462025-07-01
CLOZTECPanacea Pharmaceuticals100 mgTablet50054957PKR 3,444.142025-07-01
CLZASemos Pharmaceuticals PVT LTD25 mgTablet50's088947PKR 1,552.272025-09-05
CLZASemos Pharmaceuticals PVT LTD100 mgTablet50's088946PKR 3,395.582025-09-05
GlipinGlitz Pharma100 mgTablet5 x 10's041562PKR 3,541.312025-09-04
ImpressWerrick Pharmaceuticals100 mgTablet5x10's063374PKR 3,079.402025-08-18
Independent editorial layer

Medicine information

Clinical monographs should be independently written, referenced and medically reviewed. Product listings and advertisements must not determine clinical conclusions.